Selumetinib and Olaparib in Solid Tumors

NCT03162627 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Malignant Neoplasm of Breast
Malignant Neoplasms of Digestive Organs
Malignant Neoplasms of Female Genital Organs
Malignant Neoplasms of Male Genital Organs
Malignant Neoplasms of Thyroid and Other Endocrine Glands

Interventions

DRUG: Selumetinib
DRUG: Olaparib

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]